Microinflammation is involved in the dysfunction of arteriovenous fistula in patients with maintenance hemodialysis

Chinese Medical Journal

Volumn 121, Issue 21, 2008, Pages 2157-2161

  Liu, Bi Cheng ^a   Li, Li ^a   Gao, Min ^a   Wang, Yan Li ^a   Yu, Ji Rong ^a  

^a SOUTHEAST UNIVERSITY   (China)

Author keywords

Arteriovenous fistula; Dysfunction; Hemodialysis; Microinflammation; Uremia

Indexed keywords

C REACTIVE PROTEIN; CD68 ANTIGEN; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CHEMICAL ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS PATIENT; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATORY DISEASE; KIDNEY ARTERIOVENOUS FISTULA; MALE; NEPHELOMETRY; PROTEIN EXPRESSION; RADIAL ARTERY; SEX DIFFERENCE; TISSUE SECTION; AGED; ARTERIOVENOUS SHUNT; BLOOD; INFLAMMATION; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

ADULT; AGED; ARTERIOVENOUS SHUNT, SURGICAL; C-REACTIVE PROTEIN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 58149356760     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200811010-00010     Document Type: Article

References (24)

1. Roy-Chaudhury P, Sukhatme VP, Cheung AK. Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint. J Am Soc Nephrol 2006; 17: 1112-1127.
2. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143.
3. Tsirpanlis G, Bagos P, Ioannou D, Bleta A, Marinou I, Lagouranis A, et al. Exploring inflammation in hemodialysis patients: persistent and superimposed inflammation. A Longitudinal Study. Kidney Blood Press Res 2004; 27: 63-70.
4. Yao Q, Axelsson J, Heimburger O, Stenvinkel P, Lindholm B. Systemic inflammation in dialysis patients with end-stage renal disease: causes and consequences. Minerva Urol Nefrol 2004; 56: 237-248.
5. Sezer S, Ozdemir FN, Arat Z, Turan M, Haberal M. Triad of malnutrition, inflammation, and atherosclerosis in hemodialysis patients. Nephron 2002; 91: 456-462.
6. Blake GJ, Ridker PM. Novel clinical markers of vascular wall inflammation. Circ Res 2001; 89: 763-771.
7. Tiong AY, Brieger D. Inflammation and coronary artery disease. Am Heart J 2005; 150: 11-18.
8. Rao M, Guo D, Perianayagam MC. Plasma interleukin-6 predicts cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2005; 45: 324-333.
9. Kaysen GA, Eiserich JP. Characteristics and effects of inflammation in end-stage renal disease. Semin Dial 2003; 16: 438-446.
10. Kaysen GA. The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol 2001; 12: 1549-1557.
11. Antonio S, Elena M. Cardiac effects of chronic inflammation in dialysis patients. Nephrol Dial Transplant 2002; 17: 10-15.
12. Joseph S, Adler S. Vascular access problems in dialysis patients: pathogenesis and strategies for management. Heart Dis 2001; 3: 242-247.
13. Sukhatme VP. Vascular access stenosis: prospects for prevention and therapy. Kidney Int 1996; 49: 1161-1174.
14. Tsirpanlis G, Chatzipanaglotou S, Nicolaou C. Microinflammation versus inflammation in chronic renal failure patients. Kidney Int 2004; 66: 2093-2098.
15. Stenvinkel P. Malnutrition and chronic inflammation as risk factors for cardiovascular disease in chronic renal failure. Blood Purif 2001; 19: 143-151.
16. Tsirpanlis G, Bagos P, Ioannou D, Bleta A, Marinou I, Lagouranis A, et al. The variability and accurate assessment of microinflammation in haemodialysis patients. Nephrol Dial Transplant 2004; 19: 150-157.
17. Jenny NS, Tracy RP, Ogg MS, Luong le A, Kuller LH, Arnold AM, et al. In the elderly interleukin-6 plasma levels and the -174G>C polymorphism are associated with the development of cardiovascular disease. Arteioscler Thromb Vasc Biol 2002; 22: 2066-2071.
18. Wanner C, Zimermann J, Schwedler S, Metzger T. Inflammation and cardiovascular risk in dialysis patients. Kidney Int 2002; 61: 99-102.
19. Stenvinkel P. Inflammation in end-stage renal disease: the hidden enemy. Nephrology 2006; 11: 36-41.
20. Ballantyne CM, Nambi V. Markers of inflammation and their clinical significance. Atheroscler Suppl 2005; 6: s21-s29.
21. Pasceri V, Chang J, Willerson JT, Yeh ET. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 2001; 103: 2531-2534.
22. Libby P, Aikaw AM. Stabilization of atherosclerotic plaques: new mechanisms and clinical targets. Nature Med 2002; 8: 1257-1262.
23. Tsirpanlis G. Inflammation in atherosclerosis and other conditions: a response to danger. Kidney Blood Press Res 2005; 28: 211-217.
24. Davis C, Fischer J, Ley K, Sarembock IJ. The role of inflammation in vascular injury and repair. J Thromb Haemost 2003; 1: 1699-1709.